The Centre for Drug Research and Development (CDRD) has launched Sitka Biopharma, a spin-out which looks to commercialise bladder cancer treatment.

The new company was launched through the CDRD’s tech transfer unit CDRD Ventures, and utilises research which emerged through a collaboration between the organisation and the University of British Columbia.

Sitka’s technology offers a new treatment in an area where there are very few effective options. It combines a chemotherapeutic with a nanoparticulate drug delivery system, which has been…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?